Dishman Carbogen Amcis Limited

NSE DCAL.NS

Dishman Carbogen Amcis Limited Market Capitalization on January 14, 2025: USD 461.65 M

Dishman Carbogen Amcis Limited Market Capitalization is USD 461.65 M on January 14, 2025, a 27.77% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Dishman Carbogen Amcis Limited 52-week high Market Capitalization is USD 570.16 M on December 11, 2024, which is 23.50% above the current Market Capitalization.
  • Dishman Carbogen Amcis Limited 52-week low Market Capitalization is USD 255.63 M on June 04, 2024, which is -44.63% below the current Market Capitalization.
  • Dishman Carbogen Amcis Limited average Market Capitalization for the last 52 weeks is USD 388.68 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NSE: DCAL.NS

Dishman Carbogen Amcis Limited

CEO Mr. Pascal Villemagne
IPO Date April 22, 2004
Location India
Headquarters Dishman Corporate House
Employees 1,132
Sector Health Care
Industries
Description

Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.

Similar companies

SHILPAMED.NS

Shilpa Medicare Limited

USD 9.00

6.34%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 26.96

3.45%

BLISSGVS.NS

Bliss GVS Pharma Limited

USD 1.89

4.04%

INDOCO.NS

Indoco Remedies Limited

USD 3.76

0.04%

ERIS.NS

Eris Lifesciences Limited

USD 14.77

2.53%

StockViz Staff

January 15, 2025

Any question? Send us an email